Clinical Trial Update: SGLT-2 Inhibitors in the Treatment of Ascites

View source ↗

Summary

A University of Palermo trial is evaluating SGLT-2 inhibitors as a treatment for ascites in patients with liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis of the Liver
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT-2 inhibitors

Snippet

Sponsor: University of Palermo | Conditions: Ascites Hepatic, Cirrhosis, Liver | Status: RECRUITING